444 results on '"Esplugues, Juan V."'
Search Results
2. Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activation
3. Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients
4. THU-283 Characterisation of peptidylprolyl isomerase C as a novel player in the pathogenesis of chronic liver disease
5. THU-539 Exploring novel targets in hepatic stellate cell activation: interference with the mitochondrial function as part of the antifibrogenic effect of Rilpivirine
6. Pharmacology and safety of tofacitinib in ulcerative colitis
7. Farmacología y seguridad de tofacitinib en colitis ulcerosa
8. Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD.
9. Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less
10. p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors
11. Leukocyte–Endothelium Interaction Is Associated with Fat Mass in Children
12. Integrated transcriptomic landscape of the effect of anti‐steatotic treatments in high‐fat diet mouse models of non‐alcoholic fatty liver disease
13. Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack
14. Succinate receptor mediates intestinal inflammation and fibrosis
15. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease
16. Abacavir Induces Arterial Thrombosis in a Murine Model
17. Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects
18. Inhibition of Mitochondrial Respiration by Endogenous Nitric Oxide: A Critical Step in Fas Signaling
19. Rilpivirine as an anti-inflammatory agent in non-alcoholic fatty liver disease: evidence from human hepatocytes, hepatic stellate cells and blood cells
20. The anti-HIV drug Rilpivirine downregulates migration and proliferation of activated hepatic stellate cells: relevance for the purpose of drug repurposing in liver fibrosis
21. The flesh ethanolic extract of Hylocereus polyrhizus exerts anti-inflammatory effects and prevents murine colitis
22. Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients
23. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin‐like oxidized low‐density lipoprotein receptor‐1
24. Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte–endothelial cell interactions
25. Involvement of Nitric Oxide in the Mitochondrial Action of Efavirenz: A Differential Effect on Neurons and Glial Cells
26. Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients
27. Abacavir increases purinergic P2X7 receptor activation by ATP: does a pro-inflammatory synergism underlie its cardiovascular toxicity?
28. Neuronal Bioenergetics and Acute Mitochondrial Dysfunction: A Clue to Understanding the Central Nervous System Side Effects of Efavirenz
29. Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug‐induced toxicity in vitro
30. Looking beyond the Skin: Pathophysiology of Cardiovascular Comorbidity in Psoriasis and the Protective Role of Biologics
31. ER stress in human hepatic cells treated with Efavirenz: Mitochondria again
32. Profile of Leukocyte-Endothelial Cell Interactions Induced in Venules and Arterioles by Nucleoside Reverse-Transcriptase Inhibitors In Vivo
33. Lon protease: a novel mitochondrial matrix protein in the interconnection between drug‐induced mitochondrial dysfunction and endoplasmic reticulum stress
34. Profile of stress and toxicity gene expression in human hepatic cells treated with Efavirenz
35. Endothelial Nitric Oxide Synthase Regulates N-Ras Activation on the Golgi Complex of Antigen-Stimulated T Cells
36. ¿Es real el riesgo de osteoporosis y riesgo de fracturas con el uso crónico de inhibidores de la bomba de protones?
37. Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition
38. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis
39. Down-Regulation of the Longevity-Associated Protein SIRT1 in Peripheral Blood Mononuclear Cells of Treated HIV Patients
40. Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz
41. Interference with purinergic signalling: an explanation for the cardiovascular effect of abacavir?
42. The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction
43. Seguridad e interacciones de los inhibidores de la bomba de protones: lecciones aprendidas en millones de pacientes
44. Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines
45. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved
46. The vitamin D receptor Taq I polymorphism is associated with reduced VDR and increased PDIA3 protein levels in human intestinal fibroblasts
47. Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz
48. Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95
49. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?
50. Succinate activates EMT in intestinal epithelial cells through SUCNR1: a novel protagonist in fistula development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.